AzTrials
AzTrials

Ketogenic DietNCT07838818

Effects of Short-term Adaptation to Ketogenic Diet on Endurance Trained Athletes

A study testing Ketogenic diet in people with Ketogenic Diet and Control Condition, run by University of Padova at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Ketogenic Diet, Control Condition
What is being tested?
Ketogenic diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteItaly
Study dates
1 Nov 2024to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Age 18-40 yr,
  • BMI: 18-25 kg/m^2,
  • At least two years of endurance training experience
  • a cycling volume of at least 150 km·week
  • habitual consumption of a carbohydrate-based diet (>50% of total daily energy intake from carbohydrates)

Who cannot join

  • Chronic diseases
  • Acute inflammatory states
  • Psychiatric disorders
  • Recent (within 3 months) treatment with anabolic steroids or systemic corticosteroids

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Department of Biomedical Sciences, University of Padus

    Padova, Italy, 10034

Other trials in Italy

About this study

Official title: Glycogen Depletion, Nutritional Ketosis, and Exercise Fatigue: Novel Assessment Methods and Psychobiological Mechanisms

Skeletal muscle glycogen is a major endogenous carbohydrate store and an important substrate for ATP resynthesis during exercise. Its utilization increases with exercise intensity and duration, and low muscle glycogen availability has long been associated with impaired endurance exercise capacity. Beyond its role as a metabolic substrate, glycogen availability may influence excitation-contraction coupling and Ca²⁺ handling, providing multiple mechanisms through which carbohydrate availability can affect contractile function and fatigue.

Ketogenic diets (KD), characterized by severe carbohydrate restriction (<5% of energy intake), induce a profound redistribution of exercise metabolism. Reduced carbohydrate availability markedly increases fat oxidation while decreasing reliance on carbohydrate and muscle glycogen during exercise. This adaptation has frequently been interpreted as a glycogen-sparing mechanism that could extend endogenous carbohydrate availability during prolonged exercise. However, reduced glycogen utilization does not necessarily imply glycogen preservation, particularly when exercise begins with substantially lower muscle glycogen stores. Direct evidence quantifying muscle glycogen before and after a standardized exercise bout during ketogenic adaptation remains limited.

Read more

The marked shift toward lipid oxidation may also have consequences for exercise energetics. Fat oxidation provides less ATP per unit of oxygen consumed than carbohydrate oxidation, thereby increasing the oxygen requirement for a given rate of oxidative ATP resynthesis. This may become particularly relevant as exercise intensity and ATP demand increase, when carbohydrate-derived energy provision becomes progressively more important. Thus, ketogenic adaptation may reduce glycogen utilization while simultaneously increasing the oxygen cost of exercise and limiting the capacity to sustain higher exercise intensities. Nutritional ketosis may additionally influence exercise responses beyond skeletal muscle metabolism. KD markedly increases circulating β-hydroxybutyrate (βHB), which can be utilized as an oxidative substrate by peripheral tissues and crosses the blood-brain barrier, contributing to cerebral oxidative metabolism. Whether increased ketone availability modifies the cerebral response to exercise, and whether this relates to perceptual or exercise responses during carbohydrate restriction, remains unclear.

Accordingly, the specific aims are:

  1. To determine the effects of 10 days of ketogenic adaptation on skeletal muscle glycogen availability and utilization during standardized prolonged exercise. It is hypothesized that KD reduces resting muscle glycogen and attenuates exercise-induced glycogen utilization without preserving post-exercise glycogen availability.
  2. To determine the effects of ketogenic adaptation on substrate oxidation, exercise energetics, and exercise capacity. It is hypothesized that the shift toward greater lipid oxidation increases the oxygen cost of standardized submaximal exercise and impairs both prolonged exercise tolerance and subsequent high-intensity endurance capacity.
  3. To explore circulating substrate, perceptual, and cerebral responses to exercise during nutritional ketosis. Glucose, lactate, and βHB responses, together with prefrontal cortical oxygenation assessed by functional near-infrared spectroscopy (fNIRS), are examined to determine whether the pronounced peripheral metabolic adaptations are accompanied by detectable alterations in cerebral hemodynamic or perceptual responses.

The main hypothesis is that short-term ketogenic adaptation induces a rapid shift from carbohydrate- toward lipid-derived energy provision, but that reduced glycogen utilization does not preserve absolute skeletal muscle glycogen availability. It is further hypothesized that this metabolic redistribution increases the oxygen requirement of prolonged exercise and impairs exercise capacity, particularly as energetic demand increases.

Being tested
Ketogenic diet, Control Diet

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ketogenic dietOther

    KD (5% CHO, 2.0 g/kg/day protein)

  • Control DietOther

    Control diet: 55% CHO, 2.0 g/kg/day protein

Study groups in NCT07838818
Study groupRoleWhat they receive
KETOGENIC DIET (KD)Experimentalwill follow ketogenic diet during the intervention
Receives: Other: Ketogenic diet
CONTROL DIETActive comparatorwill follow control diet (55% carbohydrate) during the intervention
Receives: Other: Control Diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Skeletal muscle glycogen

    Resting Skeletal muscle glycogen and skeletal muscle utilization during exercise

    Measured: 10 days

  2. Endurance performance

    Overall exercise tolerance will be quantified as total exercise duration (min), defined as the combined duration of the 2-h submaximal exercise bout and the subsequent TTE. Subsequent high-intensity endurance capacity will be quantified separately as TTE duration (min) .

    Measured: 10 days

  3. Pre-frontal cortex hemodynamics and perceived fatigability during endurance exercise

    Functional near-infrared spectroscopy (fNIRS) was used to evaluate prefrontal cortex hemodynamics during exercise + questionnaire ( ROF, Feeiling scale)

    Measured: 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start1 Nov 2024
  3. Primary completion15 Oct 2026
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07838818
Sponsor's protocol ID
GLYCO-LAB
Status last verified
Sep 2026
First submitted
18 Sep 2026
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Ketogenic diet in people with Ketogenic Diet and Control Condition, run by University of Padova at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Skeletal muscle glycogen (time frame: 10 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in